These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 12702561

  • 1. Receptor activator of nuclear factor kappaB ligand plays a nonredundant role in doxorubicin-induced apoptosis.
    Müller I, Pfister SM, Grohs U, Zweigner J, Handgretinger R, Niethammer D, Bruchelt G.
    Cancer Res; 2003 Apr 15; 63(8):1772-5. PubMed ID: 12702561
    [Abstract] [Full Text] [Related]

  • 2. Collagen type I signaling reduces the expression and the function of human receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes.
    Gendron S, Couture J, Aoudjit F.
    Eur J Immunol; 2005 Dec 15; 35(12):3673-82. PubMed ID: 16304637
    [Abstract] [Full Text] [Related]

  • 3. TNF-alpha expression is transcriptionally regulated by RANK ligand.
    Zou W, Amcheslavsky A, Takeshita S, Drissi H, Bar-Shavit Z.
    J Cell Physiol; 2005 Feb 15; 202(2):371-8. PubMed ID: 15389596
    [Abstract] [Full Text] [Related]

  • 4. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression.
    Shishodia S, Aggarwal BB.
    Oncogene; 2006 Mar 09; 25(10):1463-73. PubMed ID: 16331273
    [Abstract] [Full Text] [Related]

  • 5. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
    Xiao XH, Zhou HD, Yuan LQ, Xie H, Liao EY.
    Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2102-6. PubMed ID: 15730627
    [Abstract] [Full Text] [Related]

  • 6. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N, Maeda H, Yoshimine Y, Akamine A.
    Bone; 2004 Sep 17; 35(3):629-35. PubMed ID: 15336598
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha).
    Woo JT, Nakagawa H, Krecic AM, Nagai K, Hamilton AD, Sebti SM, Stern PH.
    Biochem Pharmacol; 2005 Jan 01; 69(1):87-95. PubMed ID: 15588717
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T, Suzuki H, Nagai S, Yamamoto K, Imakiire A, Takada E, Itoh M, Mizuguchi J.
    J Orthop Res; 2003 Sep 01; 21(5):949-57. PubMed ID: 12919886
    [Abstract] [Full Text] [Related]

  • 9. Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
    Cross SS, Harrison RF, Balasubramanian SP, Lippitt JM, Evans CA, Reed MW, Holen I.
    J Clin Pathol; 2006 Jul 01; 59(7):716-20. PubMed ID: 16489180
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH.
    Free Radic Biol Med; 2006 May 01; 40(9):1483-93. PubMed ID: 16632109
    [Abstract] [Full Text] [Related]

  • 12. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
    Ichikawa H, Murakami A, Aggarwal BB.
    Mol Cancer Res; 2006 Apr 01; 4(4):275-81. PubMed ID: 16603641
    [Abstract] [Full Text] [Related]

  • 13. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M, Weller M.
    Cell Death Differ; 2003 Sep 01; 10(9):1078-89. PubMed ID: 12934082
    [Abstract] [Full Text] [Related]

  • 14. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P, Corallini F, Barbarotto E, Melloni E, di Iasio MG, Tiribelli M, Zauli G.
    J Cell Physiol; 2006 Apr 01; 207(1):158-64. PubMed ID: 16270354
    [Abstract] [Full Text] [Related]

  • 15. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system.
    Tanaka S, Nakamura K, Takahasi N, Suda T.
    Immunol Rev; 2005 Dec 01; 208():30-49. PubMed ID: 16313339
    [Abstract] [Full Text] [Related]

  • 16. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H, Ooya K.
    J Oral Pathol Med; 2005 May 01; 34(5):287-94. PubMed ID: 15817072
    [Abstract] [Full Text] [Related]

  • 17. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway.
    Wang X, Ju W, Renouard J, Aden J, Belinsky SA, Lin Y.
    Cancer Res; 2006 Jan 15; 66(2):1089-95. PubMed ID: 16424045
    [Abstract] [Full Text] [Related]

  • 18. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro.
    Yamaguchi M, Uchiyama S.
    Int J Mol Med; 2004 Jul 15; 14(1):81-5. PubMed ID: 15202020
    [Abstract] [Full Text] [Related]

  • 19. Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone.
    Zhang J, Dai J, Yao Z, Lu Y, Dougall W, Keller ET.
    Cancer Res; 2003 Nov 15; 63(22):7883-90. PubMed ID: 14633717
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.